54th Annual Meeting of the Scandinavian Society for the Study of Diabetes (SSSD) in Stockholm, April 10-12, 2019

The 54th Annual Meeting of the Scandinavian Society for the Study of Diabetes (SSSD) is to be held at World Trade Center (WTC) in Stockholm, Sweden, on April 10-12, 2019. 

The annual SSSD meetings objective is to give diabetes researchers and clinicians within the Nordic and neighbouring countries an opportunity to meet and discuss clinical and experimental diabetes research.

Registration open 


Program - SSSD2019

Wednesday April 10th

Registration (open from 10:00)

11.00 - 11.15 Opening with Welcome Remarks from the chair of the local organising committee

Malin Flodström-Tullberg

11.15 - 12.45 Session 1: Islet physiology and pathophysiology

Chair: Per-Ola Carlsson

Islet cell exocytosis in type 2 diabetes

Sebastian Barg, Uppsala University, Sweden

Diabetes from a cellular perspective

Lena Eliasson, Lund University, Sweden

Oral abstract presentations

Gonzalo Sanchez GABAergic signaling in the primary cilium of pancreatic islet β-


12.45 - 14.15 Lunch & Exhibition

13.30 - 14.00 Lunch seminar on scientific publications

Mikael Rydén, Karolinska Institutet, co-editor of Diabetologia

14.15 - 15.30 Session 1: Islet physiology and pathophysiology (continued)

Chair: Valdemar Grill

Oral abstract presentations

Anders Tengholm Glucose-induced changes of α-cell cAMP control glucagon release during hypoglycaemia

Luis Rodrigo Cataldo PP1R1A, a novel regulator of the GLP1R-amplifying glucose stimulated insulin secretion in β-cells

​Ruifeng Shi The expression and function of Clec11a in human islets

Hanna Liljebäck Fewer islets survive from first transplantation than second transplantation: evaluation of intraportal islet transplantation in mice

Anja Brboric Developing techniques for expansion and culture of neural crest stem cells isolated from human bone marrow to improve the survival and function of transplanted islets of Langerhans

Sara Ullsten Increased susceptibility for immune attack of highly blood perfused, highly metabolically active pancreatic islets

15.30 - 16.00 Coffee break and exhibition

16.00 - 17.00 Oral abstract presentations (continued)

Chair: Mikael Rydén

Type 1 diabetes – clinical aspects

Anna Korsgaard Berg The economic additional expenditure related to skin problems in patients using insulin pump and/or glucose sensor in a Danish context

Maarit K Koskinen Longitudinal pattern of first phase insulin response is associated with genetic factors outside class II HLA region in children with multiple autoantibodies

​Anmol Kumar The association between FGF23 and bone mineral density in type 1 diabetes with different stages of renal disease

​Fanny J Jansson High remnant cholesterol predicts progression of diabetic nephropathy in type 1 diabetes

​Marika Eriksson Association between blood pressure measured ambulatory and cerebral small-vessel disease in type 1 diabetes

​17.00 - 18.15 Knud Lundbeck Award lecture:

Chair: Björn Olav Åsvold

New insights into genetics of metabolic health and disease – lessons to be used in precision medicine

Torben Hansen, University of Copenhagen, Denmark​

18.30 Welcome reception, exhibition

​Thursday April 11th

08:30 - 09.45 Session 2: Imaging in diabetes

Chair: Joey Lau-Börjesson

​Eyelets in diabetes research and clinic

Per-Olof Berggren, Karolinska Institutet, Sweden

Metabolic imaging of adipose tissue in diabetes

Kirsi Virtanen, University of Eastern Finland, Finland

09.45 - 10.45 Oral abstract presentations

Chair: Lena Eliasson

Infections and islet disease

​Magdalena A Mazur Type III interferons (IFNλs) are expressed in the human type 1 diabetes pancreas at disease onset, upregulate HLA class I expression and protect beta cells from Coxsackievirus infection

​Carmen Herrera Hidalgo Neonatal infections alter islet maturation and long-term glucose homeostasis

​Kristel Parv Phagocytosis and efferocytosis by pancreatic macrophages

​Virginia M Stone A hexavalent vaccine covering all Coxsackievirus B (CVB) serotypes protects against acute CVB infection and CVB-induced diabetes in mice

​Isabel Diaz Lozano Identifying novel biomarkers for virus-induced diabetes using an experimental animal model

​10.45 - 11.15 Coffee break and exhibition​

11.15 - 12.00 The Swedish Child Diabetes Foundation's Johnny Ludvigsson Nordic Prize lecture:

Chair: Johnny Ludvigsson

Quality of care – the answer is blowing in the registries

Jannet Svensson, Copenhagen University Hospital, Denmark

12.00 - 12.45 The Swedish Child Diabetes Foundation's Johnny Ludvigsson

Prize to a Young Swedish Scientist lecture:

Chair: Johnny Ludvigsson

​Beta-cell replacement in type 1 diabetes

Joey Lau Börjesson, Uppsala University, Sweden

12.45 - 14.00 Lunch and exhibition

​13.30 - 14.00 Lunch seminar on academic innovations

Patrik Blomquist, KI Innovation, Stockholm, Sweden

​14.00 - 15.15 Session 3: Pathophysiology and prevention of type 1 diabetes

Chair: Malin Flodström-Tullberg

​Beta cell stress and development of Type 1 diabetes

Johnny Ludvigsson, Linköping University, Sweden

​Viruses and type 1 diabetes - prospects for prevention

Heikki Hyöty, University of Tampere, Finland

​15.15 - 15.45 Coffee break and exhibition

​15.45 – 17.00 Oral presentations (two parallel sessions)

 Hall 1 - Type 2 diabetes and LADA – clinical aspects

Chair: Daniel Andersson

Maria Houborg Petersen High intensity interval training combining biking and rowing markedly improves insulin sensitivity, body composition and VO2max

Maria Hornstrup Christensen Future health and gestational diabetes - the FUDGE study

​Anna P Westberg The impact of maternal weight in pregnancy on glucose tolerance and insulin resistance in non-diabetic offspring

​Sofia Carlsson Type 2 diabetes and occupation; professional drivers, manufacturing workers and cleaners are at high risk; evidence from all Swedish employees 2006-2015

​Nikolaos Tertipis High-throughput metabolomics for early detection of individuals at increased risk for type 2 diabetes

​Ingrid K Hals Insulin treatment vs. sitagliptin does not affect deterioration of insulin secretion in LADA patients. Results from a 21 month randomized study

Rebecka Hjort Physical activity and genetic susceptibility in relation to the risk of latent autoimmune diabetes in adults and type 2 diabetes

Hall 2 - Immunological aspects of type 1 diabetes

Chair: Johanna Lempainen

Louise Magnusson Identification of altered immune cell subsets in patients with autoimmune endocrine diseases by mass cytometry

Zhengkang Luo Kinetics of immune cell responses in the multiple low dose streptozotocin mouse model of type 1 diabetes

Fabricia Dietrich Immunological effects of GAD-alum injection into the lymph node in recent onset type 1 diabetes​

Hugo Barcenilla Mass cytometry identifies regulatory T and Natural Killer cell subsets that are increased in individuals at high risk for type 1 diabetes

Camilla Skoglund Increased levels of neutrophil extracellular trap (NET) remnants as well as mitochondrial and nuclear DNA in newly diagnosed type 1 diabetes children

Kailash Singh Role of regulatory B cells in clinical and experimental type 1 diabetes​

17.15 - 18.30 Session 4: Clinical Science and Care

Chair: Per-Ola Carlsson

Glucose sensor technologies in the management of type 1 diabetes

Jan Bolinder, Karolinska Institutet, Sweden

Insulin pumps, from simple injection aid to advanced technology

Anders Frid, Lund University, Sweden

18.30 – 19.15 General assembly of SSSD. Presentation of next year´s meeting

19.30 Congress Dinner World Trade Center

Friday April 12th

08:30 – 09:00 Session 4: Clinical Science and Care, continued

Chair: Per-Ola Carlsson

News from the Swedish National Diabetes Register (NDR)

Soffia Gudbjörnsdottir University of Gothenburg, Sweden

09.00 - 09.30 SSSD Young Investigator Awards

Chair: Olav Björn Åsvold

Insulin secretion depends on intra-islet glucagon signaling

Berit Svendsen, University of Copenhagen, Denmark

Sodium glucose transporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study

Peter Ueda, Karolinska Institutet, Sweden

09.30 - 10.45 Session 5: Metabolism and inflammation in type 2 diabetes

Chair: Anna Krook

Novo Nordisk Foundation Award Lecture:

Incretin therapy - Lessons learned and future directions

Bo Ahren, Lund University, Sweden

Human adipose tissue and metabolic health

Kirsty Spalding, Karolinska Institutet, Sweden

10.45 - 11.15 Coffee break (sponsored by AstraZeneca)​

11.15 - 12.30 Session 6: Precision Medicine and Drug Discovery

Chair: Olov Andersson

Translational studies to enable tailored treatment of type 2 diabetes

Anders Rosengren. University of Gothenburg, Sweden

​Towards the development of microfluidic multi-tissue models for diabetes research and drug discovery

Volker Lauschke, Karolinska Institutet, Sweden

​12.30 - 12.45 Closing of the meeting

​12.45 Lunch and farewell

Previous recipients of the Knud Lundbæk Award

1985     Ruth Østerby

1986     Carl-Erik Mogensen

1987     Arne Andersson

1988     Hans-Henrik Parving

1989     Niels Schwartz Sørensen

1990     Ulf J. Eriksson

1991     Torsten Deckert

1992     Marja-Riitta Taskinen

1993     Gisela Dahlqvist

1994     Kristian F. Hanssen

1995     Veikko Koivisto

1996     Stellan Sandler

1997     Henning Beck-Nielsen

1998     Markku Laakso

1999     Mikael Knip

2000     Oluf B. Pedersen

2001     Thomas Mandrup-Poulsen

2002     Leif Groop

2003     Oddmund Søvik

2004     Hans Ørskov

2005     Patrik Rorsman

2006     Jørn Nerup

2007     Allan Flyvbjerg

2008     Bo Ahrén

2009     Jens Juul Holst

2010     Pirjo Nuutila

2011     Juleen Zierath

2012     Allan Waag

2013     Elisabeth Mathiesen

2014     Johnny Ludvigsson

2015     Erik Renström

2016     Per-Ola Carlsson

2017     Peter Rossing

2018     Valdemar Grill


Accepted abstracts

Registration and Programme

www red DiabetologNytt